SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (2445)4/19/1999 4:49:00 PM
From: RCMac  Respond to of 10280
 
>>I wonder if Maris did the same for AZA based on the similar letter they received at just about the same time ... Somehow I suspect not.<<

No sign of any Maris comment on AZA's FDA letter. biz.yahoo.com



To: Biomaven who wrote (2445)4/19/1999 4:50:00 PM
From: j_fir2  Read Replies (2) | Respond to of 10280
 
>>It's a pity this SEPR/Maris feud has developed to this extent. There's some fault on both sides, IMO. <<

Anything you'd like to share with us? Thanks by the way for your helpful posts and gold star research.



To: Biomaven who wrote (2445)4/19/1999 4:59:00 PM
From: BMcV  Respond to of 10280
 
Not just PFE and SEPR, also Amgen and EMC, all star stock market performers with much different fundamental characteristics: techstocks.com

Really just looks like a normal correction to me.